Lipoprotein plays a role in the host defense against bacterial infection, and its serum level has been demonstrated to be an important prognosis factor of survival. We have previously demonstrated that LDL directly inactivates the hemolytic activity of Vibrio vulnificus cytolysin (VVC) in vitro. The object of this study was therefore to examine whether the LDL-mediated inactivation of VVC leads to protection against lethal infection of V. vulnificus in vivo, using wild and VVC-deficient V. vulnificus strains. Unexpectedly, we found that LDL protects mouse lethality induced by VVC-deficient as well as wild V. vulnificus strain. We also demonstrated that LDL blocks V. vulnificus LPS-induced lethality in mice. These results suggest that LDL preferentially act on endotoxin rather than exotoxin in the protection against V. vulnificus-induced mice lethality.
Introduction
Bacterial constituents within human blood are involved in the generation of bacterial sepsis and septic shock, including exotoxin, endotoxin (LPS), peptidoglycans and lipoteichoic acid. Thus, scavengers of bacterial products are expected to protect against bacterial infection and sepsis, such as plasma lipoproteins (Canturk et al., 2002; Delgado-Rodriguez et al., 2002) . Indeed, lipoproteins protect against the infection and inflammation by blocking endotoxin activity (Pajkrt et al., 1996; Netea et al., 1998) . Furthermore, recently it has been known that total cholesterol, HDL and LDL levels on admission are inversely associated with the disease severity (Wu et al., 2004 , Chien et al., 2005 , Vermont et al., 2005 . These findings suggest that lipoproteins play roles in the host defense against the bacterial infection, and its serum level is an important prognosis factor of survival. However, effect of lipoprotein on V. vulnificus infection is not clear.
V. vulnificus is known to be a life-threatening gram-negative pathogen that causes serious septicemia in human through the consumption of contaminated seafood such as oysters. V. vulnificus infection is characterized by the high fatality rates of 70% and the primary attack against people who are immunocompromised or have underlying diseases such as liver cirrhosis (Canturk et al., 2002) . V. vulnificus cytolysin (VVC) has been incriminated as a virulence factors in V. vulnificus infection (Pajkrt et al., 1996) . Indeed, antibodies against the cytolysin were detected in the blood of V. vulnificus infected mice or a human that survive V. vulnificus disease (Gray and Kreger, 1986) . These results suggest that VVC might be importantly involved in the pathogenesis of V. vulnificus infection. Thus, inactivation of VVC could be impor-tant to survival of V. vulnificus-infected host.
LDL induces the inactivation of Staphylococcus aureus α-toxin (Bhakdi et al., 1983) . Furthermore, we also found that LDL inactivates VVC hemolytic activity in vitro Kim, 2002, Park et al., 2005) . These findings suggest that LDL could prevent the toxicity of VVC and lead to survival of mice infected by V. vulnificus. Therefore, we aim to examine whether the LDL-mediated inactivation of VVC leads to protection against the lethal infection of V. vulnificus in vivo, using wild and VVCdeficient V. vulnificus strains.
Materials and Methods

Mice
Female ICR mice, 25 to 28 g weights, 6 to 7 weeks old, were obtained from the Orient Bio Inc. (Korea), were acclimated to the Chonbuk National University Medical School Facility for 5 days and fed libitum with regular chow. All experimental animals used in this study were under a protocol approved by the Institutional Animal Care and Use Committee of the Chonbuk National University. Mice were intraperitoneally injected with cultured V. vulnificus (2 × 10 8 colony forming unit (CFU)/mouse, 0.1 ml) as described by Lee et al. (2004) . Mice were pre-injected with an 0.1 ml of saline or LDL-saline solution 2 h before the bacterial injection and monitered for 72 h for their mortality.
Bacterial strain and culture
Two strains of V. vulnificus, MO6-24/O (wild strain) and CVD 707 (VVC-deficient strain) were kindly supplied by the University of Maryland School of Medicine (Wright and Morris, 1991) . Both strains were cultured in brain heart infusion (BHI) broth as described by Kreger et al. (1988) . The bacteria were precultured at 37 o C for 4 h in BHI broth (BD, Franklin Lakes, NJ) by picking one colony from the bacteria-cultivated TCBS agar plate (BD, Franklin Lakes, NJ). The stabilized bacteria were transferred to ten volume of new BHI broth, then further cultured with shacking at 37 o C for 4 h. The bacteria numbers were calculated by measurement of turbidity with a spectrophotometer (DU530, Beckman, Fullerton, CA).
LDL preparation
LDL was isolated from human plasma by the method of Koo et al. (2000) . Briefly, serum was obtained from bloods of normal healthy adults by a centrifugation at 1,200 × g for 10 min. Lipoproteins were purified by sequential preparative ultra centrifugations of serum in the presence of EDTA and protease inhibitors as preservatives. After a centrifugation of serum at 100,000 × g for 20 h at 15°C in swing bucket rotor (SW 41Ti, Beckman, Fullerton, CA), the top layer of VLDL was removed with a Pasteur pipette. The pellets in the infranatant were resuspended and adjusted to the density of 1.063 g/ml by NaBr. The LDL fraction was obtained by a centrifugation of infranatant at 100,000 × g for 24 h at 15°C. The LDL was extensively dialyzed against PBS.
V. vulnificus LPS preparation
V. vulnificus was grown in BHI broth containing 1% NaCl at 37 o C and harvested by a centrifugation at 10,000 × g for 30 min. The cells were washed with deionized water three times and soaked overnight in acetone. The cells were then centrifuged, washed twice with acetone, and dried at room temperature. LPS was prepared from the acetonedried cells by the method of Bahrani and Oliver (1991) . Briefly, 5 g of acetone-dried cells were suspended in equal volumes of preheated (69 o C) water and 90% phenol and the mixture was stirred for 15 min. After cooling on ice, the mixture was centrifuged at 10,000 × g. The aqueous phase was collected and extracted three times. The aqueous phases were pooled and dialyzed against deionized water for 3 to 5 days and then lyophilized. The fluffy powder, dissolved in 50 mM Tris-HCl, pH 7.0, was treated with bovine pancreatic RNase (40 µg/ml) and DNase I (100 µg/ml) at 37 o C for 1 h. Then, proteinase K (10 µg/ml) was added and the reaction mixture was incubated at 60 o C for 1 h. The mixture was repeatedly ultracentrifuged at 105,000 × g for 2 h until the optical density of the supernatant was less than 0.01 at 260 and 280 nm. The purified LPS was dissolved in water and lyophilized. LPS was dissolved in a saline solution and dispersed by brief sonication.
Serological analysis
Blood clinical data were obtained from the Chonbuk National University Hospital. The informed consent was obtained. The blood samples were analyzed for total cholesterol, HDL-cholesterol, LDLcholesterol, and triglycerides using an automatic blood analyzer (Hitachi, Tokyo, Japan).
Statistical Analysis
All experimental data are mean ± SD. Statistical analysis was performed using ANOVA test, Rank and Student's t test, and P ＜ 0.05 was considered to be significant.
Results
We first analyzed relationship between the severity of V. vulnificus-infected patients and serum levels of LDL cholesterol (LDLC). To assess initial serum levels of LDLC and their correlations with the clinical outcome for patients with V. vulnificus infection, we performed a retrospective study against patients (n = 16) diagnosed as V. vulnificus septicemia in the Chonbuk National University Hospital (Table 1) . Death cases (n = 12) showed lower serum levels of LDLC compared to normal patients (35.6 ± 13.9; P ＜ 0.0001, normal, ＜ 130 mg/dl), but survival cases (n = 4) showed higher levels compared to death cases and similar serum levels to normal patients (155.3 ± 40.7; P ＜ 0.0001). Moreover, total cholesterol of death cases (71.7 ± 15.7; P ＜ 0.0001, normal, ＜ 200 mg/dl) was also lower than those of survival cases (190.8 ± 40.0). These results suggest that the fatality of human V. vulnificus infection is reciprocally correlated with serum total cholesterol and LDLC. Many studies suggested that VVC might be a virulence factor for V. vulnificus infection. We demonstrated that LDL inactivates the hemolytic activity of VVC in vitro. Thus, we hypothesized that the lower survival in V. vulnificus infected patients with lower LDLC is due to lower LDL-mediated inactivation of VVC. To demonstrate this, we examined the protective effect of LDL preinjection against the lethality of mice infected with wild and VVC-deficient V. vulnificus strains. We first confirmed that VVC-deficient V. vulnificus could not produce VVC in the culture supernatant by western blotting (Figure 1) . We also examined whether exogenous LDL injection increases LDL serum level. A single peritoneal injection of LDL increased serum LDL level 1.5 times at a dose of 10 mg/kg LDL and two times at a dose of 50 mg/kg LDL 2 h after the injection compared to an injection of saline ( Figure 2A ). Wild V. vulnificus infection by a single injection of 2 × 10 8 CFU induced death of all mice within 60 h from the injection. A single injection of LDL (10 and 50 mg/kg) before the infection significantly increased survival rate in a dose dependent manner. Especially, more than 80% mice survived the infection in 50 mg/kg LDLpretreated group (n = 5) ( Figure 2B ). The difference of virulence of WT and VVC mutant was not obvious in the presence of LDL ( Figure 2C ). This finding is consistent with a previous report showing that VVC expression from V. vulnificus is not correlated to the lethality of infected mice (Wright and Morris, 1991) , suggesting that LDL-mediated inactivation of VVC is not a cause for the protective effect of LDL against V. vulnificus infection.
We next focused on which virulent constituent is blocked by LDL. LPS is a substance of outer- Figure 2 . Effect of LDL preinjection on the lethality induced by wild (B) and VVC deficient (C) V. vulnificus strains. LDL (10 and 50 mg/kg) was intraperitoneally injected to mice. Two h later, serum LDL levels was measured as described in Materials and Methods (A). Error bars, s.d.; n = 5 in each group. *P ＜ 0.002, **P ＜ 0.005, compared with saline group. Two h after LDL injection, wild type (MO6-24/O) and VVC knockout V. vulnificus (CVD707) (2 × 10 8 CFU in 0.1 ml) was intravenously injected. Survival was determined during the 3 day period after injection, after which there was no further loss of animal life. The survival rate of the group treated with LDL is significantly different from the survival rate of the control group (P ＜ 0.001 by the log rank test). membrane in gram-negative bacterium and can induce endotoxemia (Parker et al., 1995) . Thus, we purified LPS from V. vulnificus and examined whether LDL pretreatment protects V. vulnificus LPS-induced lethality. A single injection of purified LPS (20 mg/kg) from V. vulnificus induced 100% lethality within 50 h (12 mice died out of a total of 12). A single injection of LDL (10 and 50 mg/kg) before LPS injection significantly delayed V. vulnificus LPS-induced lethality in a dose dependent manner (Figure 3 ). These data suggest that LDL prevents the toxicity of V. vulnificus LPS and inhibits the lethality induced by V. vulnificus LPS.
Discussion
It has been known that serum levels of lipid, lipoproteins, and lipoprotein-associated proteins are significantly changed in patients with sepsis Pussinen et al., 2001; Carpentier and Scruel, 2002; Khovidhunkit et al., 2004) . Total cholesterol, HDL, and LDL are reduced in serum of patients with sepsis and in contrast, plasma triglyceride is elevated (Fraunberger et al., 1999; Pussinen et al., 2001; Kitchens et al., 2003; van Leeuwen et al., 2003; Khovidhunkit et al., 2004) . In this study, we observed that levels of total cholesterol, triglyceride and LDL is reduced but level of HDL is relatively unchanged in patient with V. vulnificus sepsis, which shows a different serum profile of lipid from other sepsis. Especially, LDL level is remarkably reduced in serum of patient with V. vulnificus sepsis.
We also observed a positive effect of LDL supplement at septicemia induced by V. vulnificus Figure 3 . Effect of LDL preinjection on lethality induced by purified V. vulnificus LPS. LDL (10 and 50 mg/kg) or saline was injected to mice, intraperitoneally. Two h after, LPS (20 mg/kg) was intraperitoneally infused. Survival was determined during indicated time period after injection. The survival rates of groups treated with 10 and 50 mg/kg of LDL are significantly different from the survival rate of the control group (P ＜ 0.05 and P ＜ 0.01, respectively, by log rank test).
infection in an animal model. This finding suggests that LDLC has a defense mechanism in host with V. vulnificus infection. This is consistent with a previous report that the improvements in morbidity and mortality obtained by intensive insulin therapy in critically ill patients are partially attributable to increases in the serum levels of LDL and HDL lipoproteins. The changes in septic patient lipid profile is mediated by peroxisome proliferatorsactivated receptors (PPARs) (Beigneux et al., 2000; Vanttinen et al., 2005) . Indeed, a PPAR agonist improved survival in an animal model of enotoxemia (Liu et al., 2005) . Thus PPAR agonists seem to be an attractive therapeutic tool for V. vulnificus sepsis, which is needed for further study.
